Page 3 - வெளிநாட்டு நாணய பரிமாற்றம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வெளிநாட்டு நாணய பரிமாற்றம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வெளிநாட்டு நாணய பரிமாற்றம் Today - Breaking & Trending Today

Azure Power Announces Results for Fiscal Third Quarter 2021

Azure Power Announces Results for Fiscal Third Quarter 2021
EBENE, Mauritius, Feb. 10, 2021 /PRNewswire/ Azure Power Global Limited (NYSE: AZRE), a leading independent solar power producer in India, today announced its consolidated results under United States Generally Accepted Accounting Principles ( GAAP ) for the fiscal third quarter 2021, period ended December 31, 2020.
Fiscal Third Quarter 2021 Period Ended December 31, 2020 Operating Highlights:
Operating Megawatts ( MW ) were 1,987 MWs, as of December 31, 2020, an increase of 10.0% over December 31, 2019. Operating and committed megawatts were 7,115 MWs, as of December 31, 2020, an increase of 34.2% over December 31, 2019. Committed megawatts include 4,000 MWs for which we have received Letters of Award ( LOA ) but the Power Purchase Agreements ( PPAs ) have not yet been signed. ....

New York , United States , Pawan Kumar Agrawal , Deepak Malhotra , Kuldeep Jain , Kapil Kumar , Ranjit Gupta , Gaurang Sethi , Supriya Prakash Sen , Cyril Sebastien Dominique Cabanes , Arno Harris , Samitla Subba , Jane Lun Leung , Muhammad Khalid Peyrye , Prnewswire Azure Power Global Limited , Federal Reserve Bank , Azure Power Global , Exchange Commission , Service Tax , Securities Exchange , Gain Loss On Foreign Currency Exchange , Solar Energy Corporation Of India , Power Global Limited , Third Quarter , Ended December , Power Purchase Agreements ,

IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results

IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
News provided by
Share this article
WESTBROOK, Maine, Feb. 2, 2021 /PRNewswire/
Achieves fourth quarter reported revenue growth of 19% and organic growth of 17%, driven by CAG Diagnostics recurring revenue reported growth of 23% and organic growth of 21%
High revenue growth supported by sustained strong global trends in pet healthcare
Delivers full year EPS of $6.71, an increase of 37% on a reported basis and 31% on a comparable constant currency basis
Strong full year EPS results supported by operating margin expansion of 270
basis points on a reported basis and 340 basis points on a comparable constant currency basis ....

United States , United Kingdom , Jay Mazelsky , Jonathanw Ayers , Company Water , Companion Animal Group , Company Livestock , Service Categories , Company Annual Report On Form , Exchange Commission , Laboratories Inc , Company Quarterly Report On Form , Foreign Currency Exchange Rate Assumptions , Foreign Currency Exchange , Full Year , Chief Executive , Plus Tests , African Swine Fever , Financial Performance , Recurring Revenue , Foreign Currency Exchange Rates , Private Securities Litigation Reform Act , Financial Condition , Qualitative Disclosures About Market , Annual Report , Quarterly Report ,

Stryker reports 2020 operating results and 2021 outlook

Published: Jan 27, 2021
Kalamazoo, Michigan, Jan. 27, 2021 (GLOBE NEWSWIRE) Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2020 and 2021 outlook:
The response to the COVID-19 pandemic has included measures to slow the spread of the virus taken by governments and health care authorities globally, including the postponement of deferrable medical procedures and social contact restrictions, which have had a significant negative impact on our operations and financial results.
Fourth Quarter Results
Organic net sales decreased 1.1%
Reported operating income margin of 17.6%
Adjusted operating income margin
29.2%
Adjusted EPS

%
In spite of COVID-19 outbreaks that intensified through the quarter, our teams showed good resilience and delivered a solid quarter of financial results, said Kevin Lobo, Chairman and Chief Executive Officer. As we saw with prior pandemic spikes, the impacts were ....

United States , Kevin Lobo , Wright Medical Groupnv , Drug Administration , Development Engineering Expenses , Exchange Commission , Stryker Corporation , Public Affairs , European Union , Foreign Currency Exchange , Chief Executive , Wright Medical , Consolidated Statements , Eastern Time , Investor Relations , Annual Report , Quarterly Reports , Vice President , Corporate Marketing , Three Months , Full Year December , Except Per Share Amounts , Most Directly Comparable , Stryker Reports 2020 Operating Results And 2021 Outlook , ஒன்றுபட்டது மாநிலங்களில் , கெவின் லோபோ ,